Lipitor, Atorvastatin

Lipitor, Atorvastatin Newswire

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic).

Results 1 - 20 of 578 in Lipitor, Atorvastatin (generic)

  1. Elderly should take cholesterol-lowering drugsRead the original story w/Photo

    Yesterday | New Vision

    Nearly everyone aged 66 to 75 should consider taking cholesterol-lowering drugs called statins to reduce their risk of heart attack and stroke, new guidelines published this week say. A total of 97 percent of people in the age group, and 100 percent of men, should be on the medication even if their cholesterol levels are normal, according to a study published in JAMA Internal Medicine, a journal of the American Medical Association.

    Comment?

  2. Elderly should take cholesterol-lowering statins: US studyRead the original story w/Photo

    Monday | Channelnewsasia.com

    Nearly everyone aged 66 to 75 should consider taking statins to reduce the risk of heart attack and stroke, according to a study in the JAMA Internal Medicine. WASHINGTON: Nearly everyone aged 66 to 75 should consider taking cholesterol-lowering drugs called statins to reduce their risk of heart attack and stroke, new guidelines published Monday said.

    Comment?

  3. Lipitor Lawsuit News: New Case Management Order Issued in Federal...Read the original story w/Photo

    Monday Nov 24 | PRWeb

    The Firm is investigating allegations that the use of Lipitor may increase a patient's risk of developing Type 2 diabetes. Our Firm is currently investigating allegations that Lipitor has caused some patients to develop new-onset Type 2 diabetes.

    Comment?

  4. Implications of new cholesterol guidelines on a rural Midwest communityRead the original story w/Photo

    Monday Nov 17 | Science Daily

    The health records of 4,281 New Ulm residents between the ages of 40 to 79 years old were analyzed in a new study. The data studied was from health care visits that occurred during 2012-2013, before the release of the new ACC/AHA cholesterol guidelines.

    Comment?

  5. Pharm BabesRead the original story w/Photo

    Monday Nov 24 | Patch.com

    My family physician had been a trusted and loyal personal friend for decades. When he died 11 years ago I threw away all the medications he had prescribed for me over the years.

    Comment?

  6. Early statin use may give long-term heart benefitsRead the original story

    Monday Nov 24 | The Star

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds. Doctors say it's the first evidence that early use of a statin can have a legacy effect, perhaps changing someone's odds of disease for good.

    Comment?

  7. Consumers and Obamacare users face high prices for some generic drugsRead the original story w/Photo

    Sunday Nov 23 | Examiner.com

    Consumers and pharmacies take note about the recent rise in generic drug prices. According to Med-Page Today , a pharmacy in Pennsylvania reported a mark-up of the drug, digoxin, used in heart failure patients that went from $15 in 2013 to $120 in 2014.

    Comment?

  8. Experimental Cholesterol-Lowering Drug Effective, Study ReportsRead the original story w/Photo

    Monday Nov 17 | Philly.com

    An experimental antibody drug could prove effective at lowering LDL cholesterol levels for patients who have side effects with cholesterol-lowering statin medications. The drug, alirocumab, outperformed the on-the-market medication that is currently the most widely used alternative to statins, Zetia, said lead researcher Dr. Patrick Moriarty, director of clinical pharmacology at the University of Kansas Medical Center.

    Comment?

  9. Colorado ACA exchange open for enrollmentRead the original story w/Photo

    Thursday Oct 30 | Glenwood Springs Post-Independent

    Colorado's state-run insurance exchange opened for its second year of business this month, and health officials are hoping to attract a third more customers. Connect For Health attracted about 150,000 customers in its first year.

    Comment?

  10. Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP ReportsRead the original story w/Photo

    Saturday Nov 22 | PRWeb

    Well over 1,000 claims have been filed in the Lipitor diabetes litigation since it was established this past February. Lipitor lawsuits that have been filed on behalf of patients who allegedly developed Type 2 diabetes due to its use continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports.

    Comment?

  11. A green transformation for pharmaceuticalsRead the original story w/Photo

    Friday Nov 21 | Science Daily

    A more sustainable approach to a bond-forming reaction extensively used in the pharmaceutical and fine chemical industries has now been developed. The team used the solvent-free, catalytic reaction to produce high yields of a wide range of amides, including the antidepressant moclobemide and other drug-like molecules.

    Comment?

  12. RPT-New data fuels doctors' demands to rewrite U.S. heart guidelinesRead the original story

    Friday Nov 21 | Reuters

    Controversial heart disease prevention guidelines that abandoned specific targets for reducing "bad" LDL cholesterol are under fresh assault after a major study highlighted the benefits of taking LDL to very low levels. Guidelines issued last year by the American Heart Association and the American College of Cardiology asked doctors to assess individual patients' risk for heart disease over 10 years based on a complex calculation of risks posed by lifestyle, family history and other health conditions.

    Comment?

  13. Do The IMPROVE-IT Results Offer Promise For Another Merck Heart Drug - Anacetrapib?Read the original story w/Photo

    Friday Nov 21 | Forbes.com

    I was the president of Pfizer Global Research and Development in 2007 where I managed more than 13,000 scientists and professionals in the United States, Europe, and Asia. I've received numerous awards including an Honorary Doctor of Science degree from the University of New Hampshire.

    Comment?

  14. Results announced from six Phase 3 trials showing that alirocumab...Read the original story w/Photo

    Friday Nov 21 | Medical News Today

    Sanofi and Regeneron Pharmaceuticals, Inc. has announced new detailed positive results from six Phase 3 ODYSSEY trials that showed alirocumab significantly reduced low-density lipoprotein cholesterol . Alirocumab is an investigational fully human monoclonal antibody targeting the protein PCSK9 that is being evaluated for its ability to lower LDL-C.

    Comment?

  15. New data fuels doctors' demands to rewrite U.S. heart guidelinesRead the original story

    Thursday Nov 20 | Reuters

    Controversial heart disease prevention guidelines that abandoned specific targets for reducing "bad" LDL cholesterol are under fresh assault after a major study highlighted the benefits of taking LDL to very low levels. Guidelines issued last year by the American Heart Association and the American College of Cardiology asked doctors to assess individual patients' risk for heart disease over 10 years based on a complex calculation of risks posed by lifestyle, family history and other health conditions.

    Comment?

  16. Do cholesterol-lowering statins live up to the hype?Read the original story w/Photo

    Thursday Nov 20 | Bangor Daily News

    As a doctor of chiropractic, I do not prescribe drugs. However, I am trained to look for side effects in my patients who take them.

    Comment?

  17. For Healthcare I Want The Republican Plan - Get Sick and DieRead the original story w/Photo

    Thursday Nov 20 | Daily Kos

    First, the Corporate Personhood puts Trans Fat in all our foods. Then the Pharmaceutical Personhood prescribes Lipitor to counter the Trans Fat negatives in your body.

    Comment?

  18. Using statin early can help heart for decades to comeRead the original story w/Photo

    Thursday Nov 20 | The Times-Tribune

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds. Doctors say it's the first evidence that early use of a statin can have a legacy effect, perhaps changing someone's odds of disease for good.

    Comment?

  19. Amarin riding high on new study resultsRead the original story w/Photo

    Thursday Nov 20 | The Day

    Interest in the stock of Amarin Corp. plc shot up this week with the surprise announcement that its lead heart drug, Vascepa, showed remarkable power for reducing cholesterol particles in the bloodstream. On Tuesday, Amarin was one of the hottest stocks on the Nasdaq exchange, rising more than 23 percent.

    Comment?

  20. Use of cholesterol drug in middle age lowers heart risks for decades later, study findsRead the original story w/Photo

    Wednesday Nov 19 | Canada.com

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds. Doctors say it's the first evidence that early use of a statin can have a legacy effect, perhaps changing someone's odds of disease for good.

    Comment?